Cristina Gherghe, MD, PHD
NPI: 1164629432
Total Payments
$3,307
2024 Payments
$148.61
Companies
22
Transactions
53
Medicare Patients
3,048
Medicare Billing
$261,194
Payment Breakdown by Category
Food & Beverage$3,236 (97.8%)
Gifts$59.40 (1.8%)
Education$11.71 (0.4%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,236 | 51 | 97.8% |
| Gift | $59.40 | 1 | 1.8% |
| Education | $11.71 | 1 | 0.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $508.19 | 8 | $0 (2024) |
| Lilly USA, LLC | $493.95 | 7 | $0 (2024) |
| Amgen Inc. | $489.63 | 5 | $0 (2020) |
| SANOFI-AVENTIS U.S. LLC | $254.67 | 3 | $0 (2019) |
| Medtronic MiniMed, Inc. | $247.24 | 5 | $0 (2020) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $240.00 | 2 | $0 (2019) |
| Abbott Laboratories | $138.91 | 5 | $0 (2022) |
| Alexion Pharmaceuticals, Inc. | $120.00 | 1 | $0 (2017) |
| Shire North American Group Inc | $120.00 | 1 | $0 (2018) |
| Valeritas, Inc. | $120.00 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $148.61 | 6 | Intra-Sana Laboratories ($50.00) |
| 2023 | $175.69 | 2 | Lilly USA, LLC ($116.29) |
| 2022 | $420.69 | 11 | Lilly USA, LLC ($151.92) |
| 2021 | $33.81 | 2 | Medtronic, Inc. ($17.20) |
| 2020 | $248.04 | 3 | Medtronic MiniMed, Inc. ($128.04) |
| 2019 | $856.95 | 12 | Amgen Inc. ($129.63) |
| 2018 | $734.79 | 9 | Amgen Inc. ($120.00) |
| 2017 | $688.64 | 8 | SANOFI-AVENTIS U.S. LLC ($134.67) |
All Payment Transactions
53 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/14/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $21.76 | General |
| Category: Endocrinology | ||||||
| 11/06/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $21.84 | General |
| Category: Diabetes | ||||||
| 10/16/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $13.31 | General |
| Category: Diabetes | ||||||
| 10/15/2024 | Intra-Sana Laboratories | RELTONE 400 MG (Drug), RELTONE 200 MG | Food and Beverage | Cash or cash equivalent | $50.00 | General |
| Category: GALLSTONES | ||||||
| 05/09/2024 | Radius Health, Inc. | — | Food and Beverage | In-kind items and services | $22.71 | General |
| 04/17/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $18.99 | General |
| Category: Diabetes | ||||||
| 07/18/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | Cash or cash equivalent | $116.29 | General |
| Category: Diabetes | ||||||
| 06/09/2023 | MannKind Corporation | AFREZZA (Drug) | Gift | In-kind items and services | $59.40 | General |
| Category: DIABETES MEDICINE | ||||||
| 12/16/2022 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $23.61 | General |
| Category: Diabetes | ||||||
| 12/06/2022 | Abbott Laboratories | FREESTYLE LIBRE (Device) | Food and Beverage | In-kind items and services | $71.42 | General |
| Category: Diabetes Care | ||||||
| 12/06/2022 | Abbott Laboratories | FREESTYLE LIBRE (Device) | Food and Beverage | In-kind items and services | $19.64 | General |
| Category: Diabetes Care | ||||||
| 12/01/2022 | Horizon Therapeutics plc | TEPEZZA (Drug) | Food and Beverage | In-kind items and services | $13.86 | General |
| Category: TEPEZZA | ||||||
| 08/23/2022 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | Cash or cash equivalent | $125.00 | General |
| Category: Diabetes | ||||||
| 08/19/2022 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $16.09 | General |
| 06/23/2022 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $15.21 | General |
| Category: Diabetes | ||||||
| 06/23/2022 | Lilly USA, LLC | — | Education | In-kind items and services | $11.71 | General |
| 05/25/2022 | Medtronic, Inc. | INPEN SMART INSULIN DELIVERY SYSTEM (Device) | Food and Beverage | In-kind items and services | $17.32 | General |
| Category: Continuous Glucose Monitoring | ||||||
| 05/03/2022 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $93.34 | General |
| Category: Diabetes | ||||||
| 04/20/2022 | Medtronic, Inc. | INPEN SMART INSULIN DELIVERY SYSTEM (Device) | Food and Beverage | In-kind items and services | $13.49 | General |
| Category: Continuous Glucose Monitoring | ||||||
| 11/10/2021 | LifeScan, Inc. | OneTouch Verio Reflect (Device) | Food and Beverage | In-kind items and services | $16.61 | General |
| Category: Diabetes Testing | ||||||
| 07/06/2021 | Medtronic, Inc. | Minimed 770G System (Device) | Food and Beverage | In-kind items and services | $17.20 | General |
| Category: Durable Pump | ||||||
| 11/11/2020 | Medtronic MiniMed, Inc. | Minimed 770G System (Device) | Food and Beverage | In-kind items and services | $16.93 | General |
| Category: Durable Pump | ||||||
| 02/28/2020 | Medtronic MiniMed, Inc. | Guardian Connect (Device) | Food and Beverage | In-kind items and services | $111.11 | General |
| Category: Continuous Glucose Monitoring | ||||||
| 01/14/2020 | Amgen Inc. | EVENITY (Biological) | Food and Beverage | In-kind items and services | $120.00 | General |
| Category: Bone Health | ||||||
| 12/18/2019 | Insulet Corporation | Omnipod (Device) | Food and Beverage | Cash or cash equivalent | $5.13 | General |
| Category: Insulin Pump | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 13 | 738 | 2,606 | $207,637 | $69,833 |
| 2022 | 15 | 707 | 2,545 | $192,635 | $63,277 |
| 2021 | 18 | 791 | 2,754 | $206,932 | $69,063 |
| 2020 | 18 | 812 | 2,571 | $194,910 | $59,020 |
Total Patients
3,048
Total Services
10,476
Medicare Billing
$261,194
Procedure Codes
64
All Medicare Procedures & Services
64 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0897 | Injection, denosumab, 1 mg | Office | 2023 | 17 | 1,500 | $64,200 | $27,812 | 43.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 189 | 331 | $86,195 | $27,481 | 31.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 30 | 30 | $10,500 | $3,759 | 35.8% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 127 | 232 | $8,120 | $2,171 | 26.7% |
| 95251 | Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | Office | 2023 | 41 | 77 | $8,932 | $1,971 | 22.1% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2023 | 62 | 92 | $5,060 | $1,500 | 29.6% |
| 77080 | Dxa bone density measurement of hip, pelvis, spine | Office | 2023 | 41 | 41 | $11,238 | $1,427 | 12.7% |
| 82306 | Vitamin d-3 level | Office | 2023 | 32 | 33 | $3,135 | $957.33 | 30.5% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 81 | 103 | $1,236 | $856.80 | 69.3% |
| 84439 | Thyroxine (thyroid chemical), free | Office | 2023 | 54 | 82 | $2,624 | $716.04 | 27.3% |
| 84481 | Thyroid hormone, t3 measurement, free | Office | 2023 | 25 | 38 | $2,090 | $630.80 | 30.2% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 19 | 26 | $3,362 | $276.12 | 8.2% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 20 | 21 | $945.00 | $275.52 | 29.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 174 | 352 | $91,520 | $29,093 | 31.8% |
| J0897 | Injection, denosumab, 1 mg | Office | 2022 | 14 | 1,380 | $55,200 | $23,406 | 42.4% |
| 83036 | Hemoglobin a1c level | Office | 2022 | 117 | 235 | $8,021 | $2,218 | 27.7% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2022 | 68 | 102 | $5,502 | $1,683 | 30.6% |
| 95251 | Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | Office | 2022 | 29 | 58 | $6,728 | $1,422 | 21.1% |
| 77080 | Dxa bone density measurement of hip, pelvis, spine | Office | 2022 | 37 | 37 | $10,138 | $1,298 | 12.8% |
| 84439 | Thyroxine (thyroid chemical), free | Office | 2022 | 65 | 99 | $3,072 | $876.74 | 28.5% |
| 84481 | Thyroid hormone, t3 measurement, free | Office | 2022 | 26 | 50 | $2,726 | $837.31 | 30.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 11 | 12 | $2,100 | $695.00 | 33.1% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 93 | 136 | $1,632 | $403.53 | 24.7% |
| 82306 | Vitamin d-3 level | Office | 2022 | 12 | 13 | $1,235 | $378.31 | 30.6% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2022 | 26 | 27 | $1,161 | $358.03 | 30.8% |
About Cristina Gherghe, MD, PHD
Cristina Gherghe, MD, PHD is a Endocrinology, Diabetes & Metabolism healthcare provider based in Greensboro, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/29/2007. The National Provider Identifier (NPI) number assigned to this provider is 1164629432.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Cristina Gherghe, MD, PHD has received a total of $3,307 in payments from pharmaceutical and medical device companies, with $148.61 received in 2024. These payments were reported across 53 transactions from 22 companies. The most common payment nature is "Food and Beverage" ($3,236).
As a Medicare-enrolled provider, Gherghe has provided services to 3,048 Medicare beneficiaries, totaling 10,476 services with total Medicare billing of $261,194. Data is available for 4 years (2020–2023), covering 64 distinct procedure/service records.
Ad
Practice Information
- Specialty Endocrinology, Diabetes & Metabolism
- Other Specialties Diabetes & Metabolism
- Location Greensboro, NC
- Active Since 06/29/2007
- Last Updated 08/18/2021
- Taxonomy Code 207RE0101X
- Entity Type Individual
- NPI Number 1164629432
Products in Payments
- JARDIANCE (Drug) $258.99
- MOUNJARO (Drug) $256.50
- Repatha (Biological) $240.00
- Ozempic (Drug) $230.26
- SOLIQUA (Drug) $134.67
- EVENITY (Biological) $129.63
- Kanuma (Drug) $120.00
- Macrilen (Drug) $120.00
- NATPARA (Drug) $120.00
- Prolia (Biological) $120.00
- SOLIQUA 100/33 (Drug) $120.00
- V-GO (Device) $120.00
- Xultophy 100/3.6 (Drug) $120.00
- Minimed 630G (Device) $119.20
- Omnipod (Device) $112.27
- Guardian Connect (Device) $111.11
- TRULICITY (Drug) $106.75
- t-slim insulin pump (Device) $105.26
- BAQSIMI (Drug) $100.00
- Korlym (Drug) $91.85
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Endocrinology, Diabetes & Metabolism Doctors in Greensboro
Stephen South, Md, MD
Endocrinology, Diabetes & Metabolism — Payments: $875,621
Endocrinology, Diabetes & Metabolism $875,621
Walter Kohut, M.d, M.D
Endocrinology, Diabetes & Metabolism — Payments: $17,473
Endocrinology, Diabetes & Metabolism $17,473
Dr. Ajay Kumar, Md, MD
Endocrinology, Diabetes & Metabolism — Payments: $7,072
Endocrinology, Diabetes & Metabolism $7,072
Sudan Thapa, Md, MD
Endocrinology, Diabetes & Metabolism — Payments: $1,987
Endocrinology, Diabetes & Metabolism $1,987
Komal Motwani
Endocrinology, Diabetes & Metabolism — Payments: $1,683
Endocrinology, Diabetes & Metabolism $1,683
Dr. Bindubal Balan, M.d, M.D
Endocrinology, Diabetes & Metabolism — Payments: $1,124
Endocrinology, Diabetes & Metabolism $1,124